...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Investment Banker?

..still pounding the pavement for Zenith finding a partner? (Have heard about six prospective suiters for several years now...maybe 2022 is our year?)

Share
New Message
Please login to post a reply